Page last updated: 2024-11-03
prazepam and Disease
prazepam has been researched along with Disease in 1 studies
Prazepam: A benzodiazepine that is used in the treatment of ANXIETY DISORDERS.
Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prazepam was statistically significantly superior to placebo as shown on final on-treatment scores for global improvement ratio and for the target symptoms of anxiety, tension, irritability/hostility, depressive mood, insomnia and somatization." | 6.64 | Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation. ( Weir, JH, 1978) |
| "Prazepam was statistically significantly superior to placebo as shown on final on-treatment scores for global improvement ratio and for the target symptoms of anxiety, tension, irritability/hostility, depressive mood, insomnia and somatization." | 2.64 | Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation. ( Weir, JH, 1978) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Weir, JH | 1 |
Trials
1 trial available for prazepam and Disease
| Article | Year |
|---|---|
Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation.
Topics: Adolescent; Adult; Aged; Anxiety; Depression; Disease; Double-Blind Method; Drug Evaluation; Female; | 1978 |